Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with Cerebral Cavernous Malformations
- PMID: 12404106
- DOI: 10.1038/sj.ejhg.5200870
Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with Cerebral Cavernous Malformations
Abstract
Cerebral Cavernous Malformations (CCM/MIM 604214) are vascular malformations characterised by abnormally enlarged capillary cavities without intervening brain parenchyma. Clinical manifestations include seizures, cerebral haemorrhages and focal neurological deficits. They occur as a sporadic or autosomal dominant condition. Most often, sporadic cases have only one lesion and familial cases are characterised by a high frequency of multiple lesions. Three CCM loci were previously mapped on 7q (CCM1), 7p (CCM2) and 3q (CCM3) and CCM1 gene was identified as coding Krit1, a protein of unknown function, which was shown initially to interact in yeast two hybrid assays with Rap1A, a small ras GTPase and more recently to Icap1alpha, a modulator of beta1 integrin signal transduction. Herein, we screened KRIT1 gene in 121 unrelated, consecutively recruited, CCM probands having at least one affected relative and/or showing multiple lesions on cerebral MRI. Fifty-two of these probands (43%) were shown to carry a KRIT1 mutation. Forty-two distinct mutations were identified including six recurrent ones. Three-quarters of these mutations were located in the C-terminal half of the gene, mostly within exons 13, 15 and 17. All of them are predicted to lead to a premature stop codon. No missense mutation was identified. The only two nucleotide substitutions predicted to be missense mutations led in fact to an abnormal splicing and a premature stop codon. Altogether these data suggest that KRIT1 mRNA decay due to the presence of premature stop codons and Krit1 haploinsufficiency may be the underlying mechanism of CCM.
Similar articles
-
Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.Ann Neurol. 2004 Feb;55(2):213-20. doi: 10.1002/ana.10804. Ann Neurol. 2004. PMID: 14755725
-
Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.Hum Mutat. 2008 May;29(5):709-17. doi: 10.1002/humu.20712. Hum Mutat. 2008. PMID: 18300272
-
Clinical, magnetic resonance imaging, and genetic study of 5 Italian families with cerebral cavernous malformation.Arch Neurol. 2007 Jun;64(6):843-8. doi: 10.1001/archneur.64.6.843. Arch Neurol. 2007. PMID: 17562932
-
Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.FEBS J. 2010 Mar;277(5):1070-5. doi: 10.1111/j.1742-4658.2009.07535.x. Epub 2010 Jan 22. FEBS J. 2010. PMID: 20096038 Review.
-
[Cerebral cavernous malformation--its genetic and biological background].Brain Nerve. 2008 Nov;60(11):1271-4. Brain Nerve. 2008. PMID: 19069160 Review. Japanese.
Cited by
-
KRIT1 Gene in Patients with Cerebral Cavernous Malformations: Clinical Features and Molecular Characterization of Novel Variants.J Mol Neurosci. 2021 Sep;71(9):1876-1883. doi: 10.1007/s12031-021-01814-w. Epub 2021 Mar 2. J Mol Neurosci. 2021. PMID: 33651268 Free PMC article.
-
CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletions.Neurogenetics. 2013 May;14(2):133-41. doi: 10.1007/s10048-013-0362-0. Epub 2013 Apr 18. Neurogenetics. 2013. PMID: 23595507
-
Advances in the biology of cerebral cavernous malformations.Surg Neurol Int. 2010 Oct 11;1:63. doi: 10.4103/2152-7806.70962. Surg Neurol Int. 2010. PMID: 20975979 Free PMC article.
-
Is Location Everything? Regulation of the Endothelial CCM Signaling Complex.Front Cardiovasc Med. 2022 Jul 11;9:954780. doi: 10.3389/fcvm.2022.954780. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35898265 Free PMC article. Review.
-
De novo MGC4607 gene heterozygous missense variants in a child with multiple cerebral cavernous malformations.J Mol Neurosci. 2012 Jul;47(3):475-80. doi: 10.1007/s12031-012-9741-5. Epub 2012 Mar 14. J Mol Neurosci. 2012. PMID: 22415356
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical